Medical Diagnostic Laboratories, Hamilton, NJ, has expanded its covid-19 testing menu to include an antibody detection assay for SARS-CoV-2 in human serum. The new immunological assay joins the lab’s molecular diagnostic, released in March to detect SARS-CoV-2 viral RNA in respiratory swab specimens.
“Our laboratory has always directed our resources into research by developing and enhancing tests in collaboration with our national and international clinician clients,” says Eli Mordechai, PhD, chief executive officer of Medical Diagnostic Laboratories. “We are committed to leading the way in clinical diagnostics and partnering with healthcare providers to help Americans identify and mitigate any risks to their health, protect their families, and halt the advance of this newly discovered disease.”
For more information, visit Medical Diagnostic Laboratories.